Stock listing

NASDAQ:KDMN Kadmon Holdings Inc Stock

Follow Kadmon Holdings Inc into a list and get an email when it puts out news.

Last close · NASDAQ:KDMN

$9.50 USD

Close on Nov 9, 2021 · No longer trades

Jul 27, 2016 to last close -2.1% · weekly closes, Jul 27, 2016 – Nov 9, 2021
Lowest – highest close
$1.65 – $10.23 USDSince Jul 27, 2016 · lowest Jun 25, 2019 · highest Aug 16, 2016

Delisted NASDAQ:KDMN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:KDMN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Kadmon Holdings Inc on 6ix

Decks
6 decks · latest Dec 7, 2020

Decks

DeckKindSlidesDate
Technical Presentation (December 2020)Technical18 slidesDec 7, 2020
Technical Presentation (May 2020)Technical23 slidesMay 21, 2020
Technical Presentation (November 2019)Technical16 slidesNov 13, 2019
Investor Presentation (June 2018)Investor deck25 slidesJun 11, 2018
Investor Presentation (September 2017)Investor deck26 slidesSep 25, 2017
Investor Presentation (March 2017)Investor deck34 slidesMar 8, 2017

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Arthur Kirsch
Other companies: Evommune, Inc. (Audit · Since at least Nov 5, 2025); Atea Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Liquidia Corporation (Board Member · Since at least Mar 24, 2021); Aralez Pharmaceuticals Inc (Director · May 12, 2016 – Dec 8, 2017 · Past)
Director · May 15, 2019 – Nov 9, 2021 · Past
Nancy Miller-Rich
Other companies: 4D Molecular Therapeutics, Inc. (Director · Since at least Dec 10, 2020); Aldeyra Therapeutics, Inc. (Director · Since at least Jan 13, 2020); Intercept Pharmaceuticals Inc (Director · Apr 24, 2018 – Nov 8, 2023 · Past)
Director · Aug 13, 2020 – Nov 9, 2021 · Past
Cynthia L. Flowers
Other companies: Lisata Therapeutics, Inc. (Director · Since at least Nov 7, 2018); G1 Therapeutics Inc (Director · Jun 7, 2018 – Sep 18, 2024 · Past)
Director · Jan 22, 2019 – Nov 8, 2021 · Past
Gregory S. Moss
Other companies: Evommune, Inc. (Chief Business and Legal Officer · Since at least Nov 5, 2025); Anteris Technologies Global Corp. (Director · Since at least Jun 7, 2025)
EVP, Gen. Coun. / CCO. · Aug 30, 2019 – Nov 9, 2021 · Past
Thomas E. Shenk
Other companies: MeiraGTx Holdings plc (Independent Board Member · Since at least Jun 8, 2018); Vical Incorporated (Director · Dec 18, 2015 – May 23, 2018 · Past)
Director · Jul 26, 2016 – Jun 29, 2017 · Past
Eugene Bauer
Other companies: Evommune, Inc. (Executive Director, Chief Medical Officer · Since at least Nov 5, 2025)
Director · May 15, 2019 – Nov 9, 2021 · Past
John L Ryan
Other companies: Unicycive Therapeutics, Inc. (Director · Jul 12, 2021 – Sep 5, 2023 · Past)
EVP, Chief Medical Officer · Jul 26, 2016 – Nov 9, 2021 · Past
Steven Meehan
Other companies: Twenty One Capital, Inc. (Chief Financial Officer · Since at least Dec 8, 2025)
EVP, Chief Financial Officer · Jan 17, 2017 – Nov 9, 2021 · Past
D Dixon BoardmanDirector · Jul 26, 2016 – May 15, 2019 · Past
Larry WitteExec. VP, Research & Develop. · Jul 26, 2016 – Jul 26, 2016 · Past
All 12 people
PersonSeat
Steven N GordonExec VP, GC, Chief Admin, Comp · Jul 26, 2016 – Jun 14, 2019 · Past
Zhenping ZhuExecutive VP Biologics · Jul 26, 2016 – Jul 26, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Kadmon Holdings Inc.